Unknown

Dataset Information

0

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer.

ABSTRACT: Breast cancer anti-estrogen resistance 1 (BCAR1/p130cas) is a hub for diverse oncogenic signaling cascades and promotes tumor development and progression.To understand the effect of BCAR1 in prostate cancer, we analyzed its expression on more than 11,000 prostate cancer samples. BCAR1 expression levels were compared with clinical characteristics, PSA recurrence, molecular subtype defined by ERG status and 3p, 5q, 6q and PTEN deletion.BCAR1 staining was barely detectable in normal prostate glands but seen in 77.6% of 9472 interpretable cancers, including strong expression in 38.5%, moderate in 23.2% and weak in 15.9% of cases. BCAR1 up regulation was associated with positive ERG status (p?

SUBMITTER: Heumann A 

PROVIDER: S-EPMC5756403 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

<h4>Background</h4>Breast cancer anti-estrogen resistance 1 (BCAR1/p130cas) is a hub for diverse oncogenic signaling cascades and promotes tumor development and progression.<h4>Methods</h4>To understand the effect of BCAR1 in prostate cancer, we analyzed its expression on more than 11,000 prostate cancer samples. BCAR1 expression levels were compared with clinical characteristics, PSA recurrence, molecular subtype defined by ERG status and 3p, 5q, 6q and PTEN deletion.<h4>Results</h4>BCAR1 stain  ...[more]

Similar Datasets

Unknown Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers.
| S-EPMC4452277 | biostudies-literature
Unknown PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer.
| S-EPMC5984312 | biostudies-literature
Unknown Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer.
| S-EPMC4480759 | biostudies-literature
Unknown Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers.
| S-EPMC7581599 | biostudies-literature
Unknown High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer.
| S-EPMC5343822 | biostudies-literature
Unknown Impact TMPRSS2-ERG Molecular Subtype on Prostate Cancer Recurrence.
| S-EPMC8234735 | biostudies-literature
Unknown HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy.
| S-EPMC4494977 | biostudies-literature
Unknown High expression of SLCO2B1 is associated with prostate cancer recurrence after radical prostatectomy.
| S-EPMC5865664 | biostudies-literature
Unknown Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA.
| S-EPMC3245713 | biostudies-literature
Unknown Prostate cancer genes associated with TMPRSS2-ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts.
| S-EPMC2822948 | biostudies-literature